What is the recommended dose of dimenhydrinate injection (50 mg/mL) in children expressed in milliliters per kilogram?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dimenhydrinate Injection Dosing in Children

For intramuscular administration in children, the dose is 1.25 mg/kg of body weight (or 37.5 mg/m² of body surface area) administered four times daily, with a maximum daily dose not exceeding 300 mg. 1

Converting to mL/kg for 50 mg/mL Concentration

Since dimenhydrinate injection is supplied as 50 mg/mL, the volume-based dosing is:

  • 0.025 mL/kg per dose (1.25 mg/kg ÷ 50 mg/mL = 0.025 mL/kg)
  • Given four times daily (every 6 hours)
  • Maximum 300 mg/day total

Route-Specific Administration

Intramuscular (IM):

  • Inject 0.025 mL/kg (1.25 mg/kg) directly as needed, up to four times daily 1

Intravenous (IV):

  • Must dilute each 1 mL (50 mg) in 10 mL of 0.9% Sodium Chloride Injection
  • Inject over a period of 2 minutes 1
  • Calculate the child's dose in mg, then dilute accordingly

Important Clinical Considerations

Common pitfalls to avoid:

  • Do not exceed 300 mg total daily dose regardless of weight 1
  • IV administration requires mandatory dilution—never give undiluted IV
  • The drug causes drowsiness, which should be anticipated 1

Practical example: A 20 kg child would receive:

  • 1.25 mg/kg × 20 kg = 25 mg per dose
  • Volume: 0.5 mL of the 50 mg/mL solution
  • Can be given up to 4 times daily (total 100 mg/day, well below 300 mg maximum)

The FDA-approved labeling provides clear weight-based dosing that is straightforward to calculate and does not require complex allometric scaling for this antihistamine medication 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.